For the pentose phosphate pathway, glucose‐6‐phosphate dehyrdogenase (G6PD) was decreased by 45% in AD relative to controls, while phosphogluconate dehydrogenase (PGD) was unchanged (Figure 3P,Q). This evidence concerns the gene PGD and Alzheimer disease.